Cargando…

Pathogenic Variant Spectrum in Breast Cancer Risk Genes in Finnish Patients

SIMPLE SUMMARY: The Finnish population has evolved through multiple reductions in the population size, which have caused decreased genetic diversity in the population. This may affect the risk variant spectrum in diseases such as breast cancer (BC) so that a few variants may cover most of the pathog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nurmi, Anna K., Suvanto, Maija, Dennis, Joe, Aittomäki, Kristiina, Blomqvist, Carl, Nevanlinna, Heli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776204/ https://www.ncbi.nlm.nih.gov/pubmed/36551643 http://dx.doi.org/10.3390/cancers14246158

Ejemplares similares

Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients
por: Nurmi, Anna, et al.
Publicado: (2019)

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families
por: Pelttari, Liisa M, et al.
Publicado: (2015)

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families
por: Muranen, Taru A., et al.
Publicado: (2016)

SNPs in lncRNA Regions and Breast Cancer Risk
por: Suvanto, Maija, et al.
Publicado: (2020)

NTHL1 is a recessive cancer susceptibility gene
por: Nurmi, Anna K., et al.
Publicado: (2023)

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
por: Hallamies, Sanna, et al.
Publicado: (2017)

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

Comprehensive analysis of NuMA variation in breast cancer
por: Kilpivaara, Outi, et al.
Publicado: (2008)

Variants on the promoter region of PTEN affect breast cancer progression and patient survival
por: Heikkinen, Tuomas, et al.
Publicado: (2011)

ATM variants and cancer risk in breast cancer patients from Southern Finland
por: Tommiska, Johanna, et al.
Publicado: (2006)

BACH1 Ser919Pro variant and breast cancer risk
por: Vahteristo, Pia, et al.
Publicado: (2006)

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
por: Kiiski, Johanna I., et al.
Publicado: (2017)

Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2008)

Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer
por: Khan, Sofia, et al.
Publicado: (2017)

Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility
por: Mantere, Tuomo, et al.
Publicado: (2017)

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
por: Muranen, Taru A, et al.
Publicado: (2011)

MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer
por: Peurala, Hanna, et al.
Publicado: (2011)

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer
por: Alhopuro, Pia, et al.
Publicado: (2020)

Familial Breast Cancer in Southern Finland
por: Eerola, Hannaleena, et al.
Publicado: (1999)

A Genome Wide Meta-Analysis Study for Identification of Common Variation Associated with Breast Cancer Prognosis
por: Rafiq, Sajjad, et al.
Publicado: (2014)

Multi-Variant Pathway Association Analysis Reveals the Importance of Genetic Determinants of Estrogen Metabolism in Breast and Endometrial Cancer Susceptibility
por: Low, Yen Ling, et al.
Publicado: (2010)

High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome
por: Jamshidi, Maral, et al.
Publicado: (2021)

Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer
por: Muranen, Taru A., et al.
Publicado: (2020)

FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome
por: Kiiski, Johanna I., et al.
Publicado: (2016)

Mast cells and eosinophils in invasive breast carcinoma
por: Amini, Rose-Marie, et al.
Publicado: (2007)

High cyclin B1 expression is associated with poor survival in breast cancer
por: Aaltonen, K, et al.
Publicado: (2009)

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
por: Li, Yuqing, et al.
Publicado: (2011)

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
por: Muranen, Taru A., et al.
Publicado: (2023)

Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients
por: Pelttari, Liisa M, et al.
Publicado: (2012)

Incidence and familial risk of premature ovarian insufficiency in the Finnish female population
por: Silvén, H, et al.
Publicado: (2022)

Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families
por: Arason, Adalgeir, et al.
Publicado: (2010)

Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk
por: Onay, Ummiye V, et al.
Publicado: (2008)

Data Integration Workflow for Search of Disease Driving Genes and Genetic Variants
por: Karinen, Sirkku, et al.
Publicado: (2011)

Germline TP53 mutations in Finnish breast cancer patients
por: Rapakko, K, et al.
Publicado: (2000)

A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients
por: Wendt, Camilla, et al.
Publicado: (2021)

Other short opinions/comments on moderate/low cancer genetic risk markers in medical practice and the article Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology by Lubinski et al., Breast Cancer Res Treat 2008 Apr 15
por: Aittomäki, Kristiina
Publicado: (2008)

Breastfeeding attitudes of Finnish parents during pregnancy
por: Laanterä, Sari, et al.
Publicado: (2010)

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
por: Jönsson, Göran, et al.
Publicado: (2010)

Bacteriological etiology and treatment of mastitis in Finnish dairy herds
por: Vakkamäki, Johanna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pv4v8g95j8sbjqhefbu3k73mqi